AAAAAA

   
Results: 1-8 |
Results: 8
RECOMMENDATIONS FOR THE REGISTRATION OF DRUGS USED IN THE TREATMENT OF RHEUMATOID-ARTHRITIS
Authors: LEMMEL EM REID DM NUKI G AVOUAC B BARDIN T BOUVENOT G CAUWENBERGE H CLUZEL M DEVOLGELAER JP DUFF GW EMERY P ETHGEN D KREUTZ G MENKES CJ REIDEL H SERNI U VANDERAUWERA P VEYS E WHITEGUAY B REGINSTER JY
Citation: Em. Lemmel et al., RECOMMENDATIONS FOR THE REGISTRATION OF DRUGS USED IN THE TREATMENT OF RHEUMATOID-ARTHRITIS, British journal of rheumatology, 37(2), 1998, pp. 211-215
EFFECTS OF A POTENT PLATELET-ACTIVATING-FACTOR ANTAGONIST, SR27417A, ON ALLERGEN-INDUCED ASTHMATIC RESPONSES
Authors: EVANS DJ BARNES PJ CLUZEL M OCONNOR BJ
Citation: Dj. Evans et al., EFFECTS OF A POTENT PLATELET-ACTIVATING-FACTOR ANTAGONIST, SR27417A, ON ALLERGEN-INDUCED ASTHMATIC RESPONSES, American journal of respiratory and critical care medicine, 156(1), 1997, pp. 11-16
IN-VITRO ANTIBACTERIAL ACTIVITY OF THE NE W FLUOROQUINOLONE SPARFLOXACIN ON NOSOCOMIAL BACTERIA, AND CONCORDANCE CURVE
Authors: SOUSSY CJ CLUZEL M DERLOT E EXMELIN L KITZIS M DABERNAT H LENOC P MULLERSERIEYS C REVERDY ME SCHEFTEL JM THABAUT A
Citation: Cj. Soussy et al., IN-VITRO ANTIBACTERIAL ACTIVITY OF THE NE W FLUOROQUINOLONE SPARFLOXACIN ON NOSOCOMIAL BACTERIA, AND CONCORDANCE CURVE, Pathologie et biologie, 44(4), 1996, pp. 241-248
IN-VITRO ACTIVITY OF NEW FLUOROQUINOLONE, ENOXACIN, AGAINST HOSPITAL ISOLATES AND REGRESSION CURVE - A MULTICENTER STUDY
Authors: SOUSSY CJ CLUZEL M MEYRAN M
Citation: Cj. Soussy et al., IN-VITRO ACTIVITY OF NEW FLUOROQUINOLONE, ENOXACIN, AGAINST HOSPITAL ISOLATES AND REGRESSION CURVE - A MULTICENTER STUDY, Pathologie et biologie, 43(4), 1995, pp. 274-280
MOLECULAR-CLONING AND EXPRESSION OF ALPHA-PARVALBUMIN IN THE GUINEA-PIG COCHLEA
Authors: SOTOPRIOR A CLUZEL M RENARD N RIPOLL C LAVIGNEREBILLARD M EYBALIN M HAMEL CP
Citation: A. Sotoprior et al., MOLECULAR-CLONING AND EXPRESSION OF ALPHA-PARVALBUMIN IN THE GUINEA-PIG COCHLEA, Molecular brain research, 34(2), 1995, pp. 337-342
SR-27417, A NOVEL, HIGHLY POTENT AND LONG-ACTING PAF RECEPTOR ANTAGONIST
Authors: HERBERT JM BERNAT A VALETTE G CLUZEL M MAFFRAND JP
Citation: Jm. Herbert et al., SR-27417, A NOVEL, HIGHLY POTENT AND LONG-ACTING PAF RECEPTOR ANTAGONIST, Journal of lipid mediators and cell signalling, 10(1-2), 1994, pp. 149-150
SINGLE RISING ORAL DOSE OF SR 27417A, A SPECIFIC PAF RECEPTOR ANTAGONIST IN HUMANS - TOLERABILITY AND PHARMACOLOGICAL ASSESSMENT
Authors: WYLD P NIMMO W HOLLAND T HERBERT JM CLUZEL M
Citation: P. Wyld et al., SINGLE RISING ORAL DOSE OF SR 27417A, A SPECIFIC PAF RECEPTOR ANTAGONIST IN HUMANS - TOLERABILITY AND PHARMACOLOGICAL ASSESSMENT, Journal of lipid mediators and cell signalling, 10(1-2), 1994, pp. 155-157
IN-VITRO ACTIVITY OF A NEW FLUOROQUINOLON E, FLEROXACIN AGAINST HOSPITAL ISOLATES AND REGRESSION CURVE - A MULTICENTER STUDY
Authors: SOUSSY CJ CLUZEL M DERLOT E KITZIS MD MEYRAN M
Citation: Cj. Soussy et al., IN-VITRO ACTIVITY OF A NEW FLUOROQUINOLON E, FLEROXACIN AGAINST HOSPITAL ISOLATES AND REGRESSION CURVE - A MULTICENTER STUDY, Pathologie et biologie, 42(5), 1994, pp. 385-392
Risultati: 1-8 |